1.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.07
Offen:
$1.05
24-Stunden-Volumen:
68,173
Relative Volume:
0.68
Marktkapitalisierung:
$64.38M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-3.2384
EPS:
-0.3582
Netto-Cashflow:
$-19.17M
1W Leistung:
+12.62%
1M Leistung:
+12.62%
6M Leistung:
+10.48%
1J Leistung:
+41.17%
Cytosorbents Corp Stock (CTSO) Company Profile
Firmenname
Cytosorbents Corp
Sektor
Branche
Telefon
973-329-8885
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Vergleichen Sie CTSO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CTSO
Cytosorbents Corp
|
1.16 | 64.38M | 33.79M | -18.67M | -19.17M | -0.3582 |
![]()
ABT
Abbott Laboratories
|
129.38 | 227.16B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
101.14 | 140.69B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
361.05 | 132.32B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
84.30 | 105.94B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.13 | 41.90B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
2020-09-17 | Eingeleitet | Jefferies | Buy |
2020-09-01 | Eingeleitet | SVB Leerink | Outperform |
2017-08-08 | Bestätigt | Maxim Group | Buy |
2016-10-26 | Eingeleitet | Aegis Capital | Buy |
2016-05-24 | Eingeleitet | Maxim Group | Buy |
2015-10-29 | Hochstufung | WBB Securities | Speculative Buy → Buy |
2015-05-12 | Bestätigt | MLV & Co | Buy |
2015-04-01 | Bestätigt | MLV & Co | Buy |
2015-03-05 | Eingeleitet | MLV & Co | Buy |
2015-02-25 | Eingeleitet | WBB Securities | Speculative Buy |
2015-01-27 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
CytoSorbents secures $1.7M via NJ tax credit transfer - Investing.com
CytoSorbents Lands $1.7M Strategic Funding: New DrugSorb Product Launch and Manufacturing Expansion Ahead - Stock Titan
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - PR Newswire
Cytosorbents Appoints Thomas Shannon As Vice President Of Marketing For North America - marketscreener.com
Strategic Hire: Medtronic $450M Portfolio Leader Joins CytoSorbents to Drive Breakthrough Device Launch - Stock Titan
Raymond James Financial Inc. Takes Position in Cytosorbents Co. (NASDAQ:CTSO) - Defense World
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World
Analysts Offer Predictions for Cytosorbents Q1 Earnings - Defense World
Brokers Offer Predictions for Cytosorbents Q1 Earnings - Defense World
Analysts Set Expectations for Cytosorbents FY2028 Earnings - Defense World
Cytosorbents (NASDAQ:CTSO) Earns “Neutral” Rating from HC Wainwright - Defense World
CytoSorbents extends Series B Warrants expiration to June 10 - Investing.com
Cytosorbents CorpExtends Expiration Date Of Series B Right Warrants To June 10, 2025SEC Filing - MarketScreener
CytoSorbents extends Series B Warrants expiration to June 10 By Investing.com - Investing.com UK
CytoSorbents Gives Investors More Time: Series B Warrants Now Extended to June 2025 - Stock Titan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
Cytosorbents Corp Reports Strong Growth Amid Challenges - TipRanks
CytoSorbents Corp Q4 2024 Earnings: EPS Misses at -$0.06, Revenue Falls Short at $9.2 Million - GuruFocus
The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts - Benzinga
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript - Insider Monkey
CytoSorbents: Q4 Earnings Snapshot - CT Insider
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Stron - GuruFocus
CytoSorbents Corporation Reports Strong 2024 Performance - TipRanks
Earnings call transcript: Cytosorbents Crp Q4 2024 beats EPS forecast By Investing.com - Investing.com Canada
CTSOCytosorbents Corp Latest Stock News & Market Updates - Stock Titan
Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cytosorbents Corp SEC 10-K Report - TradingView
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - TradingView
CYTOSORBENTS Earnings Results: $CTSO Reports Quarterly Earnings - Nasdaq
Cytosorbents (CTSO) Expected to Post Improved Earnings and Reven - GuruFocus
Insights into CytoSorbents's Upcoming Earnings - Benzinga
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What t - GuruFocus.com
Cytosorbents (CTSO) Expected to Announce Quarterly Earnings on Monday - Defense World
CytoSorbents Corp (CTSO) Reports Q4 Revenue Between $9.0M and $9 - GuruFocus
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Longview News-Journal
CytoSorbents Q4 Revenue Jumps 25% Despite Earnings DelayKey Metrics Released - StockTitan
Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
CytoSorbents Stock Price, Quotes and Forecasts | NASDAQ:CTSO - Benzinga
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Yahoo Finance
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents Corp. to Host Earnings Call - ACCESS Newswire
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024 -March 04, 2025 at 04:52 pm EST - Marketscreener.com
CytoSorbents delays earnings call after VP’s passing - Investing.com India
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):